Mallardo, Domenico
Sparano, Francesca
Vitale, Maria Grazia
Trojaniello, Claudia
Fordellone, Mario
Cioli, Eleonora
Esposito, Assunta
Festino, Lucia
Mallardo, Mario
Vanella, Vito
Facchini, Bianca Arianna
De Filippi, Rosaria
Meinardi, Paolo
Ottaviano, Margaret
Caracò, Corrado
Simeone, Ester
Ascierto, Paolo Antonio
Article History
Received: 29 February 2024
Accepted: 10 May 2024
First Online: 8 June 2024
Declarations
:
: PAA has/had a consultant/advisory role for Bristol Myers Squibb, Roche-Genentech, Merck Sharp & Dohme, Novartis, Merck Serono, Pierre-Fabre, AstraZeneca, Sun Pharma, Sanofi, Idera, Sandoz, Immunocore, 4SC, Italfarmaco, Nektar, Boehringer-Ingelheim, Eisai, Regeneron, Daiichi Sankyo, Pfizer, Oncosec, Nouscom, Lunaphore, Seagen, iTeos, Medicenna, Bio-Al Health. He also received research funding from Bristol Myers Squibb, Roche-Genentech, Pfizer, Sanofi. AC received grant consultancies from BMS, Astrazeneca, Roche and MSD. He also received speaker’s fee from Astrazeneca, Novartis and Eisai.
: All procedures performed were in accordance with the 1964 Helsinki Declaration and its later amendments. The present study was notified to the Ethics Committee of Istituto Nazionale Tumori—IRCCS—Fondazione “G. Pascale”, Naples, Italy, protocol n.37/22 oss.
: Informed consent was obtained from all individual participants included in the study.
: The patients released informed consent to the publication of anonymous data.